Conduit Pharmaceuticals (NASDAQ:CDT) Shares Set to Reverse Split on Monday, January 27th

Conduit Pharmaceuticals Inc. (NASDAQ:CDT) shares are scheduled to reverse split on Monday, January 27th. The 1-100 reverse split was announced on Thursday, January 23rd. The number of shares owned by shareholders will be adjusted after the market closes on Friday, January 24th.

Conduit Pharmaceuticals Stock Performance

NASDAQ CDT traded down $0.01 on Thursday, reaching $0.05. 46,306,568 shares of the stock traded hands, compared to its average volume of 143,065,000. Conduit Pharmaceuticals has a 12 month low of $0.05 and a 12 month high of $3.92. The firm’s fifty day simple moving average is $0.08 and its 200 day simple moving average is $0.13.

Conduit Pharmaceuticals Company Profile

Conduit Pharmaceuticals Inc, a clinical-stage specialty biopharmaceutical company, develops pharmaceutical products that provides unmet medical needs in the areas of autoimmune diseases and idiopathic male infertility. Its pipeline includes AZD1656, which has completed Phase I trials for the treatment of type 2 diabetes, renal transplant, Hashimoto's thyroiditis and Grave's disease, uveitis, and preterm labor; and AZD5904, which has completed Phase I clinical trials for the treatment of idiopathic male infertility.